tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Pro-Dex Extends Major Customer Contract Through 2028

Story Highlights
  • Pro-Dex extended its largest customer contract to December 31, 2028.
  • The three-year extension includes minimum 2026–2027 purchases, supporting revenue visibility and growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Pro-Dex Extends Major Customer Contract Through 2028

Claim 70% Off TipRanks This Holiday Season

The latest update is out from Pro-Dex ( (PDEX) ).

On December 19, 2025, Pro-Dex, Inc. announced that it executed a contract amendment on December 17, 2025, extending its agreement with its largest customer for three additional years, from a prior termination date of December 31, 2025, to a new end date of December 31, 2028. The renewed contract includes minimum purchase volumes for 2026 and 2027, reinforcing what will become more than 15 years of collaboration with this key customer and providing greater visibility into future revenue, which management says positions the company for continued revenue growth and underscores its strategy of maintaining long-term relationships with major clients.

The most recent analyst rating on (PDEX) stock is a Buy with a $41.00 price target. To see the full list of analyst forecasts on Pro-Dex stock, see the PDEX Stock Forecast page.

Spark’s Take on PDEX Stock

According to Spark, TipRanks’ AI Analyst, PDEX is a Outperform.

Pro-Dex’s overall stock score reflects strong financial performance and attractive valuation. The company’s robust revenue growth and profitability are significant strengths, though cash flow challenges need attention. Technical indicators suggest short-term bullish momentum, but resistance may be encountered at higher levels.

To see Spark’s full report on PDEX stock, click here.

More about Pro-Dex

Pro-Dex, Inc. is a medical technology company that designs, develops and manufactures autoclavable, battery-powered and electric multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic and maxillofacial markets. The company, which serves mainly medical device distributors, leverages patented adaptive torque-limiting software and proprietary sealing solutions, and also provides engineering, quality and regulatory consulting services, while sales of its rotary air motors to various industries represent only a minimal portion of its business.

Average Trading Volume: 49,397

Technical Sentiment Signal: Strong Buy

Current Market Cap: $140.6M

For a thorough assessment of PDEX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1